Product Information
LORAZEPAM 2 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.0697 per EA under NDC 13107008505. Its NADAC has been published 132 times since Feb 14, 2024.
FDA first approved this application on Dec 22, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107008505
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA203572FDA Approved
12/22/2017
TE Code
AB
On Market Since
2/1/2021
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 2 MG TABLET has been published 132 times since Feb 14, 2024, and over the history we have for it it has declined 9.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0697 per EA |
|---|---|
| All-time high | $0.0768 (Feb 14, 2024) |
| All-time low | $0.0523 (Nov 20, 2024) |
| 52-week high | $0.0764 |
| 52-week low | $0.0695 |
| Median price | $0.0707 |
| Average price | $0.0705 |
| Largest weekly change | -30.9% (Nov 20, 2024) |
| Weeks tracked | 132 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LORAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.0697 per EA (NDC 13107008505), effective Aug 19, 2026.
How has the price of LORAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 2 MG TABLET has declined 9.2%. It has been tracked across 132 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG TABLET?
Since Feb 14, 2024, the NADAC for LORAZEPAM 2 MG TABLET has ranged from a low of $0.0523 (Nov 20, 2024) to a high of $0.0768 (Feb 14, 2024), with a median of $0.0707 per EA.
Are there cheaper alternatives to LORAZEPAM 2 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LORAZEPAM 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LORAZEPAM 2 MG TABLET?
LORAZEPAM 2 MG TABLET (NDC 13107008505) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.